Sanofi/GSK restart COVID-19 vaccine trials after tweaking formulation Sanofi and GlaxoSmithKline are restarting clinical development of their COVID-19 vaccine, which was delayed after hitting a snag ...
Biogen's treatment for neurodegenerative disorder spinal muscular atrophy (SMA) Spinraza has come under pressure in an increasingly competitive market, but the company hopes a new high-dose ...
BEIJING -- China's Ministry of Industry and Information Technology (MIIT) will formulate an action plan for green and low-carbon development of the manufacturing industry, a spokesperson said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback